secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001156039-24-000119
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q3 adjusted EPS $8.37; FY2024 guidance cut to ~$33.00
---------------------------------------------------------------------

- Q3 2024 operating revenue $44.7B, up $2.2B YoY; diluted EPS $4.36 GAAP, adjusted $8.37.
- Benefit expense ratio 89.5%, up 270 bps driven by Medicaid rate-acuity mismatch; operating margin 3.1% (adj 5.3%).
- Medical membership ~45.8M, down 1.5M (3%) due to Medicaid attrition and footprint adjustments.
- Board authorized $8.0B increase to share repurchase program; Q4 dividend $1.63/share declared.
- FY2024 GAAP EPS guidance ~$26.50, adjusted EPS ~$33.00, reflecting Medicaid headwinds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/0001156039-24-000119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/elv-20241017.htm
  HTML page:      https://secwatch.observer/filing/0001156039-24-000119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer